Guillain-Barre syndrome -: A prospective, population-based incidence and outcome survey

被引:161
作者
Chiò, A
Cocito, D
Leone, M
Giordana, MT
Mora, G
Mutani, R
机构
[1] Univ Turin, Dept Neurosci, I-10126 Turin, Italy
[2] San Giovanni Battista Hosp, Turin, Italy
[3] A Avogadro Univ, Div Neurol, Novara, Italy
[4] San Luigi Hosp, Orbassano, Italy
[5] IRCCS, Sci Inst Veruno, Clin Lavoro Riabilit, Fondaz S Maugeri,Dept Neurol Rehabil, Verona, Italy
关键词
D O I
10.1212/01.WNL.0000055091.96905.D0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The authors evaluated the incidence and long-term prognostic factors of Guillain-Barre syndrome (GBS) in a prospective, population-based study. Methods: Patients with GBS diagnosed according to National Institute of Neurological and Communicative Disorders and Stroke criteria in the 2-year period 1995 to 1996 in two Italian regions were prospectively followed up for 2 years after onset of GBS. Results: A total of 120 patients were found, corresponding to a crude annual incidence rate of 1.36/100,000 population (95% CI, 1.13 to 1.63). A total of 7 (5.8%) patients, all but one with axonal or mixed EMG pattern, died acutely within 30 days from the onset of the disease. Acute mortality was due to respiratory involvement and intensive care unit complications. In multivariate analysis, a worse 2-year outcome (Hughes score 2) was related to a higher Hughes grade at nadir, axonal or mixed EMG, age greater than or equal to50 years, and absence of respiratory infections preceding GBS. The persistence of disability 2 years after the acute phase was related to axonal involvement and a worse status at nadir. Conclusions: After adjustment to US population, the incidence rates for GBS from different countries showed no significant differences. Both acute mortality and long-term disability in GBS seem to be related to an axonal involvement and a Hughes grade greater than or equal to2 at nadir.
引用
收藏
页码:1146 / 1150
页数:5
相关论文
共 47 条
  • [1] Alam TA, 1998, MUSCLE NERVE, V21, P1275, DOI 10.1002/(SICI)1097-4598(199810)21:10<1275::AID-MUS5>3.0.CO
  • [2] 2-8
  • [3] THE EPIDEMIOLOGY OF GUILLAIN-BARRE-SYNDROME
    ALTER, M
    [J]. ANNALS OF NEUROLOGY, 1990, 27 : S7 - S12
  • [4] [Anonymous], 1978, Ann Neurol, V3, P565
  • [5] Beghi E, 1996, BRAIN, V119, P2053
  • [6] The Guillain-Barre syndrome (GBS) - Implementation of a register of the disease on a nationwide basis
    Beghi, E
    Bogliun, G
    [J]. ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (05): : 355 - 361
  • [7] BEGHI E, 1985, ARCH NEUROL-CHICAGO, V42, P1053, DOI 10.1001/archneur.1985.04060100035016
  • [8] CASTELLA A, 2000, VIEW REV HOSP, V4, P28
  • [9] Epidemiological surveillance of Guillain-Barre syndrome in Sweden, 1996-1997
    Cheng, Q
    Jiang, GX
    Fredrikson, S
    Link, H
    de Pedro-Cuesta, J
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (02): : 104 - 110
  • [10] CORNBLATH DR, 1991, NEUROLOGY, V41, P617